stockrow
Friday 6 November 2026
Export AMGN’s income statement to Excel — free account
Amgen Inc.
AMGN Healthcare Drug Manufacturers General
Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024.
- Revenue
- +8.45%
- EPS
- +19.4%
- Free cash flow
- −0.16%
- Total debt
- −1.06%
Quarter to September 2026, against a year earlier
461.57
1.29
+0.28%
Follow AMGN
Alert me
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
38,085.00 | 41,678.00 | 29,304.00 | 8,911.00 | 10,647.00 | 8,037.00 | 9,305.00 | 10,944.00 | 11,973.00 | 9,129.00 |
Receivables |
3,165.00 | 3,237.00 | 3,580.00 | 4,057.00 | 4,525.00 | 4,895.00 | 5,563.00 | 7,268.00 | 6,782.00 | 9,570.00 |
Inventory |
2,745.00 | 2,834.00 | 2,940.00 | 3,584.00 | 3,893.00 | 4,086.00 | 4,930.00 | 9,518.00 | 6,998.00 | 6,225.00 |
Other current assets |
2,015.00 | 1,727.00 | 1,794.00 | 1,888.00 | 2,079.00 | 2,367.00 | 2,388.00 | 2,602.00 | 3,277.00 | 4,133.00 |
Total current assets |
46,010.00 | 49,476.00 | 37,618.00 | 18,440.00 | 21,144.00 | 19,385.00 | 22,186.00 | 30,332.00 | 29,030.00 | 29,057.00 |
Property, Plant, Equpment (Net) |
4,961.00 | 4,989.00 | 4,958.00 | 4,928.00 | 4,889.00 | 5,184.00 | 5,427.00 | 5,941.00 | 6,543.00 | 7,913.00 |
Goodwill and Intangible Assets (Total) |
25,030.00 | 23,370.00 | 22,142.00 | 34,116.00 | 31,276.00 | 30,072.00 | 31,609.00 | 51,270.00 | 46,336.00 | 40,956.00 |
Long-term assets (Other) |
1,625.00 | 2,119.00 | 1,698.00 | 2,223.00 | 5,639.00 | 6,524.00 | 5,899.00 | 9,611.00 | 9,930.00 | 12,660.00 |
Total non-current assets |
31,616.00 | 30,478.00 | 28,798.00 | 41,267.00 | 41,804.00 | 41,780.00 | 42,935.00 | 66,822.00 | 62,809.00 | 61,529.00 |
Total Assets |
77,626.00 | 79,954.00 | 66,416.00 | 59,707.00 | 62,948.00 | 61,165.00 | 65,121.00 | 97,154.00 | 91,839.00 | 90,586.00 |
Accounts Payable |
917.00 | 1,352.00 | 1,207.00 | 1,371.00 | 1,421.00 | 1,366.00 | 1,572.00 | 1,590.00 | 1,908.00 | 2,367.00 |
Accrued Expenses |
5,884.00 | 6,516.00 | 7,862.00 | 8,511.00 | 10,141.00 | 10,731.00 | 12,524.00 | 15,359.00 | 17,641.00 | 18,523.00 |
Current Part of Debt |
4,403.00 | 1,152.00 | 4,419.00 | 2,953.00 | 91.00 | 87.00 | 1,591.00 | 1,443.00 | 3,550.00 | 4,599.00 |
Total current liabilities |
11,204.00 | 9,020.00 | 13,488.00 | 12,835.00 | 11,653.00 | 12,184.00 | 15,687.00 | 18,392.00 | 23,099.00 | 25,489.00 |
Long Term Debt (Total) |
30,193.00 | 34,190.00 | 29,510.00 | 26,950.00 | 32,895.00 | 33,222.00 | 37,354.00 | 63,170.00 | 56,549.00 | 50,005.00 |
Long Term Tax Liability (Deferred) |
2,436.00 | 1,166.00 | 864.00 | 606.00 | (287.00) | — | 11.00 | 2,354.00 | 1,616.00 | 1,366.00 |
Non-current Liabilities (Other) |
3,918.00 | 10,337.00 | 10,054.00 | 10,249.00 | 8,991.00 | 9,059.00 | 8,408.00 | 7,006.00 | 4,698.00 | 5,068.00 |
Total non-current liabilities |
36,547.00 | 45,693.00 | 40,428.00 | 37,199.00 | 41,886.00 | 42,281.00 | 45,773.00 | 72,530.00 | 62,863.00 | 56,439.00 |
Total liabilities |
47,751.00 | 54,713.00 | 53,916.00 | 50,034.00 | 53,539.00 | 54,465.00 | 61,460.00 | 90,922.00 | 85,962.00 | 81,928.00 |
Common Stock (Net) |
30,784.00 | 30,992.00 | 31,246.00 | 31,531.00 | 31,802.00 | 32,096.00 | 32,514.00 | 33,070.00 | 33,533.00 | 34,023.00 |
Retained Earnings |
(438.00) | (5,072.00) | (17,977.00) | (21,330.00) | (21,408.00) | (24,600.00) | (28,622.00) | (26,549.00) | (27,590.00) | (25,107.00) |
Common Equity (Total) |
29,875.00 | 25,241.00 | 12,500.00 | 9,673.00 | 9,409.00 | 6,700.00 | 3,661.00 | 6,232.00 | 5,877.00 | 8,658.00 |
Shareholders Equity (Total) |
29,875.00 | 25,241.00 | 12,500.00 | 9,673.00 | 9,409.00 | 6,700.00 | 3,661.00 | 6,232.00 | 5,877.00 | 8,658.00 |
Shareholders Equity and Liabilities (Total) |
77,626.00 | 79,954.00 | 66,416.00 | 59,707.00 | 62,948.00 | 61,165.00 | 65,121.00 | 97,154.00 | 91,839.00 | 90,586.00 |
Shares (Common) |
738.20 | 722.20 | 629.60 | 591.40 | 578.30 | 558.30 | 534.00 | 535.40 | 536.90 | 538.80 |
Shareholders Equity (Tangible) |
4,845.00 | 1,871.00 | (9,642.00) | (24,443.00) | (21,867.00) | (23,372.00) | (27,948.00) | (45,038.00) | (40,459.00) | (32,298.00) |
Net Debt |
(3,489.00) | (6,336.00) | 4,625.00 | 20,992.00 | 22,339.00 | 25,272.00 | 29,640.00 | 53,669.00 | 48,126.00 | 45,475.00 |
Total Debt |
34,596.00 | 35,342.00 | 33,929.00 | 29,903.00 | 32,986.00 | 33,309.00 | 38,945.00 | 64,613.00 | 60,099.00 | 54,604.00 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 5 Nov 2026